Explore evidence

45 patientsThe study included 45 COVID-19 patients with a mean age of 43 years and standard deviation of 16 years.

NigeriaCOVID-19observed 2020published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observations

1.41 AORHaving COVID-19 symptoms but not tested was associated with increased odds of depression related to COVID-19 (adjusted odds ratio: 1.41).

NigeriaCOVID-19observed 2020published 2022Frontiers in public healthPubMeddocument of 10 observations

1.4 DOT_per_LOTPatients with moderate COVID-19 had a mean days of therapy per length of therapy (DOT per LOT) of 1.4.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

6.8 %Among 73 participants with diabetes mellitus, 6.8% had received a COVID-19 vaccination.

NigeriaCOVID-19 · diabète (non précisé)observed March-May 2021published 2022International journal of environmental research and public healthPubMeddocument of 12 observations

29 %Among the 45 COVID-19 patients, 29% presented with cough.

NigeriaCOVID-19observed 2020published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observations

97.2 %Among community health workers in selected States of Nigeria, 97.20% adhere to COVID-19 prevention-protocols.

NigeriaCOVID-19published 2022The Pan African medical journalPubMeddocument of 10 observations

1.61 AORHaving COVID-19 symptoms but not tested was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 1.61).

NigeriaCOVID-19observed 2020published 2022Frontiers in public healthPubMeddocument of 10 observations

0.09 per_100000The incidence of confirmed COVID-19 cases in Nigeria ranged from 0.09 per 100,000 in Kogi to 83.7 per 100,000 in Lagos.

NigeriaCOVID-19published 2020The Pan African medical journalPubMeddocument of 6 observations

2 %The overall case fatality rate was 2%.

NigeriaCOVID-19observed March to August 2020published 2021The Pan African medical journalPubMeddocument of 14 observations

24 %The pooled hospitalisation rate for SARS-CoV-2 infection was 24%.

NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 4 observations

The coronavirus disease 2019 outbreak in Nigeria was first reported on the 27th February 2020.

NigeriaCOVID-19observed 2020-02-27published 2020The Nigerian postgraduate medical journaleurope_pmcdocument of 7 observations

36.1 %Fever was present in 36.1% of RT-PCR-negative patients and 18.8% of RT-PCR-positive patients.

NigeriaCOVID-19observed 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations

1.3 DOT_per_LOTPatients with severe COVID-19 received antimicrobial therapy with a mean DOT per LOT of 1.3.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

10,000 casesThe number of confirmed coronavirus disease 2019 cases in Nigeria reached 10,000 on the 31st May 2020.

NigeriaCOVID-19observed 2020-05-31published 2020The Nigerian postgraduate medical journaleurope_pmcdocument of 7 observations

2.5 aORHypoxemia was an independent predictor of in-hospital mortality with an adjusted odds ratio of 2.5.

NigeriaCOVID-19observed 2020published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observations

17.8 %Thirty-eight (17.8%) of 213 prepandemic samples from Nigeria tested positive on the Euroimmun NCP IgG assay.

NigeriaCOVID-19published 2021Journal of clinical microbiologyPubMeddocument of 6 observations

1 patientOne patient had decompensated heart failure.

NigeriaCOVID-19 · insuffisance cardiaquepublished 2021Cardiovascular journal of AfricaPubMeddocument of 8 observations

Overall, SARS-CoV-2 infectivity rates were higher in 2021 than in 2022.

NigeriaCOVID-19published 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15051187

0.15 aORHausa ethnicity was associated with decreased odds of severe SARS-CoV-2 disease (adjusted odds ratio 0.15, 95% CI: 0.04–0.62).

NigeriaCOVID-19observed April to July 2020published 2022The Pan African medical journalPubMeddocument of 13 observations

26 %Among 73 participants with diabetes mellitus, 26.0% either refused or remained hesitant towards taking the COVID-19 vaccine.

NigeriaCOVID-19 · diabète (non précisé)observed March-May 2021published 2022International journal of environmental research and public healthPubMeddocument of 12 observations

500 ppmWiping with 500 ppm of bleach for 5 minutes completely reduces SARS-CoV-2 virus on kraft paper and polypropylene.

NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 5 observations

40 %19 out of 48 Community Pharmacies (40%) scored at least 90% for service quality in COVID-19 antigen rapid diagnostic testing evaluation in the Federal Capital Territory of Nigeria between September 2022 and February 2023.

NigeriaCOVID-19observed September 2022 to February 2023published 2024PloS onePubMeddocument of 5 observations

64.4 %Among 73 participants with diabetes mellitus, 64.4% experienced COVID-19 symptoms.

NigeriaCOVID-19 · diabète (non précisé)observed March-May 2021published 2022International journal of environmental research and public healthPubMeddocument of 12 observations

12 %The pooled prevalence of SARS-CoV-2 infection among exposed healthcare workers was 12%.

NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 4 observations

21.1 %Seroprevalence of SARS-CoV-2 infection among people living with HIV in Nigeria ranged between 21.1% in Ekiti State in January 2023 and 71.4% in Gombe State in November 2022.

NigeriaCOVID-19observed January 2023published 2025International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 2 observations